Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05933629

Community-based Implementation of Online EmReg

Community-based Implementation of an Emotion Regulation Intervention for Individuals With Traumatic Brain Injury

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
Icahn School of Medicine at Mount Sinai · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This is a hybrid type III implementation-effectiveness trial; this study design blends elements of implementation and clinical effectiveness research, with the primary aim of determining the utility of an implementation strategy and a secondary aim of assessing clinical outcomes associated with the implementation trial. Consistent with best practices for this type of design, the study team will conduct a randomized test of the effect of implementation strategy on effective delivery of the Online EmReg intervention in clinical practice. Specifically, the study team will compare Standard Training (a 3-hour on-demand training workshop) to Extended Training, (a 3-hour on-demand training workshop with 3 months of bi-weekly consultation). The research team's primary aim is to determine the optimal strategy to train clinicians in effectively delivering Online EmReg, and secondary aim is to assess patient improvement per clinician-administered DERS. Outcome measures will be assessed via self-report surveys, performance evaluations (via role-plays), and tracked clinician participation and fidelity. Study participation is expected to last up to 18 months.

Conditions

Interventions

TypeNameDescription
BEHAVIORALOnline EmRegA Web-based group intervention to improve emotion regulation in individuals with traumatic brain injury (TBI). Online EmReg is a 3-hour on-demand training workshop
BEHAVIORALConsultation Sessions3 months of bi-weekly consultation sessions

Timeline

Start date
2023-07-18
Primary completion
2027-05-31
Completion
2027-05-31
First posted
2023-07-06
Last updated
2025-04-06

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05933629. Inclusion in this directory is not an endorsement.